ArticleCancer research communications2024

Impact of Neoadjuvant Immunotherapy on Recurrence-Free Survival in Patients with High-Risk Localized HCC.

Mari Nakazawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.